Literature DB >> 22473396

Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology Group.

Susan E Puumala1, Julie A Ross, James H Feusner, Gail E Tomlinson, Marcio H Malogolowkin, Mark D Krailo, Logan G Spector.   

Abstract

BACKGROUND: A recent study suggested a markedly increased risk of hepatoblastoma (HB) among children conceived with treatment for infertility. However, it is not clear whether this finding is confounded by the association between HB and low birthweight (LBW).
METHODS: Associations between parental infertility and its treatment and HB were examined using data from a case-control study conducted through the Children's Oncology Group (COG). Telephone interviews were completed for 383 mothers of cases diagnosed with HB at US COG institutions between January 2000 and December 2008 and for 387 mothers of controls recruited through state birth registries. Logistic regression was used to examine possible associations.
RESULTS: After adjusting for birthweight and other potential confounders, no significant association was found for any of the measures of parental infertility or its treatment. In HB cases conceived through assisted reproductive technology (ART), 4 of 16 also had Beckwith-Wiedemann syndrome (BWS) compared with 9 of 365 in HB cases without ART.
CONCLUSIONS: Little evidence of an association between parental infertility or its treatment and HB was found. The relationship found in a previous study could be due to LBW and BWS which are risk factors for HB and also associated with parental infertility and its treatment.

Entities:  

Mesh:

Year:  2012        PMID: 22473396      PMCID: PMC3357199          DOI: 10.1093/humrep/des109

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  51 in total

1.  Methylation pattern at the KvDMR in a child with Beckwith-Wiedemann syndrome conceived by ICSI.

Authors:  M V Gomes; C C Gomes; W Pinto; E S Ramos
Journal:  Am J Med Genet A       Date:  2007-03-15       Impact factor: 2.802

2.  Secular trends in response rates for controls selected by random digit dialing in childhood cancer studies: a report from the Children's Oncology Group.

Authors:  Greta R Bunin; Logan G Spector; Andrew F Olshan; Leslie L Robison; Michelle Roesler; Seymour Grufferman; Xiao-ou Shu; Julie A Ross
Journal:  Am J Epidemiol       Date:  2007-04-23       Impact factor: 4.897

3.  Assisted reproductive therapies and imprinting disorders--a preliminary British survey.

Authors:  A G Sutcliffe; C J Peters; S Bowdin; K Temple; W Reardon; L Wilson; J Clayton-Smith; L A Brueton; W Bannister; E R Maher
Journal:  Hum Reprod       Date:  2005-12-16       Impact factor: 6.918

4.  The epigenetic imprinting defect of patients with Beckwith-Wiedemann syndrome born after assisted reproductive technology is not restricted to the 11p15 region.

Authors:  S Rossignol; V Steunou; C Chalas; A Kerjean; M Rigolet; E Viegas-Pequignot; P Jouannet; Y Le Bouc; C Gicquel
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

5.  Trends in childhood cancer incidence in the U.S. (1992-2004).

Authors:  Amy M Linabery; Julie A Ross
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

Review 6.  Fetal and neonatal hepatic tumors.

Authors:  Hart Isaacs
Journal:  J Pediatr Surg       Date:  2007-11       Impact factor: 2.545

7.  Infertility, assisted reproduction technologies and imprinting disturbances: a Dutch study.

Authors:  Marianne E Doornbos; Saskia M Maas; Joseph McDonnell; Jan P W Vermeiden; Raoul C M Hennekam
Journal:  Hum Reprod       Date:  2007-06-23       Impact factor: 6.918

8.  Feasibility of nationwide birth registry control selection in the United States.

Authors:  Logan G Spector; Julie A Ross; Susan E Puumala; Michelle Roesler; Andrew F Olshan; Greta R Bunin
Journal:  Am J Epidemiol       Date:  2007-07-10       Impact factor: 4.897

9.  Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome: a report from the Children's Oncology Group.

Authors:  Susan E Puumala; Julie A Ross; Andrew F Olshan; Leslie L Robison; Franklin O Smith; Logan G Spector
Journal:  Cancer       Date:  2007-11-01       Impact factor: 6.860

10.  Perinatal risk factors for hepatoblastoma.

Authors:  L G Spector; K J Johnson; J T Soler; S E Puumala
Journal:  Br J Cancer       Date:  2008-04-08       Impact factor: 7.640

View more
  14 in total

1.  What do we know about the etiology of hepatoblastoma?

Authors:  Lucie M Turcotte; Logan G Spector
Journal:  Hepat Oncol       Date:  2013-12-20

2.  Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children's Oncology Group.

Authors:  Amanda E Janitz; Gurumurthy Ramachandran; Gail E Tomlinson; Mark Krailo; Michaela Richardson; Logan Spector
Journal:  J Expo Sci Environ Epidemiol       Date:  2017-03-08       Impact factor: 5.563

3.  Risk of Cancer in Children Conceived by Assisted Reproductive Technology.

Authors:  Marte Myhre Reigstad; Inger Kristin Larsen; Tor Åge Myklebust; Trude Eid Robsahm; Nan Birgitte Oldereid; Louise A Brinton; Ritsa Storeng
Journal:  Pediatrics       Date:  2016-02-04       Impact factor: 7.124

4.  Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's Oncology Group.

Authors:  Lucie M Turcotte; Michael K Georgieff; Julie A Ross; James H Feusner; Gail E Tomlinson; Marcio H Malogolowkin; Mark D Krailo; Nicole Miller; Rachel Fonstad; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2014-07-15       Impact factor: 3.167

5.  Parental tobacco and alcohol use and risk of hepatoblastoma in offspring: a report from the children's oncology group.

Authors:  Kimberly J Johnson; Katherine S Williams; Julie A Ross; Mark D Krailo; Gail E Tomlinson; Marcio H Malogolowkin; James H Feusner; Logan G Spector
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-08-15       Impact factor: 4.254

Review 6.  Children's Oncology Group's 2013 blueprint for research: epidemiology.

Authors:  Logan G Spector; Julie A Ross; Andrew F Olshan
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

Review 7.  Children's Oncology Group's 2013 blueprint for research: rare tumors.

Authors:  Carlos Rodriguez-Galindo; Mark Krailo; Lindsay Frazier; Murali Chintagumpala; James Amatruda; Howard Katzenstein; Marcio Malogolowkin; Logan Spector; Farzana Pashankar; Rebecka Meyers; Gail Tomlinson
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

8.  Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB).

Authors:  Rajkumar Venkatramani; Logan G Spector; Michael Georgieff; Gail Tomlinson; Mark Krailo; Marcio Malogolowkin; Wendy Kohlmann; Karen Curtin; Rachel K Fonstad; Joshua D Schiffman
Journal:  Am J Med Genet A       Date:  2014-06-16       Impact factor: 2.802

Review 9.  ART and health: clinical outcomes and insights on molecular mechanisms from rodent studies.

Authors:  S K Feuer; L Camarano; P F Rinaudo
Journal:  Mol Hum Reprod       Date:  2012-12-20       Impact factor: 4.025

Review 10.  Long-term follow-up of children conceived through assisted reproductive technology.

Authors:  Yue-hong Lu; Ning Wang; Fan Jin
Journal:  J Zhejiang Univ Sci B       Date:  2013-05       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.